PDB Short entry for 2BKS HEADER HYDROLASE 18-FEB-05 2BKS TITLE CRYSTAL STRUCTURE OF RENIN-PF00074777 COMPLEX CAVEAT 2BKS PZ1 B 401 HAS WRONG CHIRALITY AT ATOM C12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE, ASPARTIC PROTEINASE, ASPARTYL PROTEASE, GLYCOPROTEIN, KEYWDS 2 PLASMA, ZYMOGEN, POLYMORPHISM EXPDTA X-RAY DIFFRACTION AUTHOR N.A.POWELL,E.H.CLAY,D.D.HOLSWORTH,J.J.EDMUNDS,J.W.BRYANT,J.M.RYAN, AUTHOR 2 M.JALAIE,E.ZHANG REVDAT 3 21-JUL-21 2BKS 1 CAVEAT COMPND SOURCE REMARK REVDAT 3 2 1 DBREF HELIX SHEET SITE REVDAT 3 3 1 ATOM REVDAT 2 24-FEB-09 2BKS 1 VERSN REVDAT 1 05-APR-06 2BKS 0 JRNL AUTH N.A.POWELL,E.H.CLAY,D.D.HOLSWORTH,J.W.BRYANT,J.M.RYAN, JRNL AUTH 2 M.JALAIE,E.ZHANG,J.J.EDMUNDS JRNL TITL EQUIPOTENT ACTIVITY IN BOTH ENANTIOMERS OF A SERIES OF JRNL TITL 2 KETOPIPERAZINE-BASED RENIN INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 15 2371 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15837327 JRNL DOI 10.1016/J.BMCL.2005.02.085 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.4 REMARK 3 NUMBER OF REFLECTIONS : 44271 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 4455 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5080 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.390 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 34.61 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BKS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-FEB-05. REMARK 100 THE DEPOSITION ID IS D_1290022933. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47471 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 39.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.95800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.95800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 70.95800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.95800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.95800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 70.95800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 70.95800 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 70.95800 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 70.95800 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 70.95800 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 70.95800 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 70.95800 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 70.95800 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 70.95800 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 70.95800 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 70.95800 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 70.95800 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 70.95800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: HIGHLY SPECIFIC ENDOPEPTIDASE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A -4 REMARK 465 THR A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 ASN A 0 REMARK 465 THR A 1 REMARK 465 THR A 2 REMARK 465 SER A 163A REMARK 465 GLN A 163B REMARK 465 SER A 163C REMARK 465 LEU B -4 REMARK 465 THR B -3 REMARK 465 LEU B -2 REMARK 465 GLY B -1 REMARK 465 ASN B 0 REMARK 465 THR B 1 REMARK 465 THR B 2 REMARK 465 SER B 163A REMARK 465 GLN B 163B REMARK 465 SER B 163C REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 162 CG CD OE1 OE2 REMARK 470 ASN A 163 CA C O CB CG OD1 ND2 REMARK 470 GLU B 162 CG CD OE1 OE2 REMARK 470 ASN B 163 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 11 22.10 48.02 REMARK 500 ARG A 48 2.42 -69.11 REMARK 500 ASN A 70 -61.60 -141.60 REMARK 500 SER A 161 -143.50 44.01 REMARK 500 GLU A 162 -59.43 82.40 REMARK 500 SER A 206 95.49 166.56 REMARK 500 ALA A 292 30.01 -81.52 REMARK 500 ALA B 52 0.39 -67.76 REMARK 500 LEU B 76 114.50 -167.27 REMARK 500 TYR B 78 174.81 -54.34 REMARK 500 SER B 79 -163.32 -57.08 REMARK 500 THR B 80 -119.81 38.05 REMARK 500 GLU B 162 -74.47 -75.87 REMARK 500 SER B 205 -11.42 -172.25 REMARK 500 THR B 207 75.59 -66.88 REMARK 500 ASP B 212 9.44 85.13 REMARK 500 ARG B 244 -96.92 -68.29 REMARK 500 ALA B 292 32.26 -96.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZ1 B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AO5 RELATED DB: PDB REMARK 900 MOUSE GLANDULAR KALLIKREIN-13 (PRORENIN CONVERTING ENZYME) REMARK 900 RELATED ID: 1BBS RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 1BIL RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 1BIM RELATED DB: PDB REMARK 900 RENIN REMARK 900 RELATED ID: 1E80 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133 REMARK 900 RELATED ID: 1E81 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395 REMARK 900 RELATED ID: 1E82 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601 REMARK 900 RELATED ID: 1EED RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE CYCLOHEXYL RENIN INHIBITOR PD125754 REMARK 900 RELATED ID: 1HRN RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH POLYHYDROXYMONOAMIDE INHIBITOR BILA 980 REMARK 900 RELATED ID: 1MPP RELATED DB: PDB REMARK 900 PEPSIN (RENIN) REMARK 900 RELATED ID: 1PR7 RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH COMPOUND IB REMARK 900 RELATED ID: 1PR8 RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 1QZ9 RELATED DB: PDB REMARK 900 THE THREE DIMENSIONAL STRUCTURE OF KYNURENINASE FROMPSEUDOMONAS REMARK 900 FLUORESCENS REMARK 900 RELATED ID: 1RNE RELATED DB: PDB REMARK 900 RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) COMPLEX WITH CGP 38'560 REMARK 900 RELATED ID: 1SMR RELATED DB: PDB REMARK 900 RENIN COMPLEX WITH THE INHIBITOR CH-66 REMARK 900 RELATED ID: 1UHQ RELATED DB: PDB REMARK 900 HUMAN RENIN COMPLEXED WITH A SUBSTITUTED PIPERIDINE REMARK 900 RELATED ID: 1W7L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I REMARK 900 RELATED ID: 1W7M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I IN COMPLEX REMARK 900 WITH L-PHE REMARK 900 RELATED ID: 1W7N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I IN PMP FORM REMARK 900 RELATED ID: 2BKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RENIN-PF00257567 COMPLEX REMARK 900 RELATED ID: 2PHV RELATED DB: PDB REMARK 900 HIV-2 PROTEASE (HIV-2 PR) COMPLEX WITH RENIN INHIBITOR H261 (BOC- REMARK 900 HIS-PRO-PHE-LEU PSI[CHOH-CH2]-VAL-ILE-HIS (THEORETICAL MODEL) REMARK 900 RELATED ID: 2REN RELATED DB: PDB REMARK 900 RENIN DBREF 2BKS A -4 333 UNP P00797 RENI_HUMAN 67 406 DBREF 2BKS B -4 333 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG SEQRES 1 B 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 B 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 B 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 B 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 B 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 B 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 B 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 B 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 B 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 B 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 B 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 B 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 B 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 B 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 B 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 B 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 B 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 B 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 B 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 B 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 B 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 B 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 B 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 B 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 B 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 B 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 B 340 ALA ARG HET PZ1 B 401 43 HETNAM PZ1 (6R)-6-({[1-(3-HYDROXYPROPYL)-1,7-DIHYDROQUINOLIN-7- HETNAM 2 PZ1 YL]OXY}METHYL)-1-(4-{3-[(2-METHOXYBENZYL) HETNAM 3 PZ1 OXY]PROPOXY}PHENYL)PIPERAZIN-2-ONE FORMUL 3 PZ1 C34 H41 N3 O6 FORMUL 4 HOH *172(H2 O) HELIX 1 AA1 TYR A 50 TYR A 55 1 6 HELIX 2 AA2 ASP A 60 SER A 64 5 5 HELIX 3 AA3 PRO A 110 MET A 115 1 6 HELIX 4 AA4 PHE A 127 VAL A 135 5 9 HELIX 5 AA5 PRO A 137 SER A 144 1 8 HELIX 6 AA6 ASP A 175 GLN A 177 5 3 HELIX 7 AA7 SER A 228 GLY A 240 1 13 HELIX 8 AA8 ASN A 253 GLY A 255 5 3 HELIX 9 AA9 THR A 273 VAL A 278 1 6 HELIX 10 AB1 GLY A 309 ARG A 314 1 6 HELIX 11 AB2 TYR B 50 VAL B 54 5 5 HELIX 12 AB3 ASP B 60 SER B 64 5 5 HELIX 13 AB4 PRO B 113 ALA B 117 5 5 HELIX 14 AB5 PHE B 127 VAL B 135 5 9 HELIX 15 AB6 PRO B 137 GLN B 145 1 9 HELIX 16 AB7 ASP B 175 GLN B 177 5 3 HELIX 17 AB8 SER B 228 GLY B 240 1 13 HELIX 18 AB9 GLU B 254 LEU B 258 5 5 HELIX 19 AC1 THR B 273 TYR B 277 1 5 HELIX 20 AC2 GLY B 309 LYS B 315 1 7 SHEET 1 AA1 9 LYS A 68 ARG A 77 0 SHEET 2 AA1 9 THR A 82 VAL A 94 -1 O VAL A 83 N LEU A 76 SHEET 3 AA1 9 GLN A 14 ILE A 21 -1 N GLY A 20 O THR A 93 SHEET 4 AA1 9 SER A 4 TYR A 10 -1 N THR A 8 O TYR A 16 SHEET 5 AA1 9 GLY A 167 LEU A 171 -1 O ILE A 169 N VAL A 5 SHEET 6 AA1 9 VAL A 152 TYR A 157 -1 N TYR A 156 O GLN A 168 SHEET 7 AA1 9 PHE A 316 ASP A 321 -1 O PHE A 320 N PHE A 153 SHEET 8 AA1 9 ARG A 326 ALA A 332 -1 O GLY A 328 N GLU A 319 SHEET 9 AA1 9 TYR A 179 ASN A 187 -1 N ILE A 186 O ILE A 327 SHEET 1 AA213 LYS A 68 ARG A 77 0 SHEET 2 AA213 THR A 82 VAL A 94 -1 O VAL A 83 N LEU A 76 SHEET 3 AA213 ILE A 97 GLU A 108 -1 O GLU A 105 N PHE A 86 SHEET 4 AA213 VAL A 39 PRO A 42 1 N VAL A 39 O GLY A 104 SHEET 5 AA213 GLY A 121 GLY A 124 -1 O VAL A 122 N TRP A 40 SHEET 6 AA213 GLN A 26 ASP A 33 1 N VAL A 31 O VAL A 123 SHEET 7 AA213 GLN A 14 ILE A 21 -1 N GLY A 17 O VAL A 30 SHEET 8 AA213 SER A 4 TYR A 10 -1 N THR A 8 O TYR A 16 SHEET 9 AA213 GLY A 167 LEU A 171 -1 O ILE A 169 N VAL A 5 SHEET 10 AA213 VAL A 152 TYR A 157 -1 N TYR A 156 O GLN A 168 SHEET 11 AA213 PHE A 316 ASP A 321 -1 O PHE A 320 N PHE A 153 SHEET 12 AA213 ARG A 326 ALA A 332 -1 O GLY A 328 N GLU A 319 SHEET 13 AA213 TYR A 179 ASN A 187 -1 N ILE A 186 O ILE A 327 SHEET 1 AA3 5 GLN A 195 MET A 198 0 SHEET 2 AA3 5 CYS A 214 VAL A 218 -1 O ALA A 216 N ILE A 196 SHEET 3 AA3 5 TRP A 306 LEU A 308 1 O LEU A 308 N LEU A 217 SHEET 4 AA3 5 ILE A 225 GLY A 227 -1 N SER A 226 O ALA A 307 SHEET 5 AA3 5 ILE A 293 ALA A 295 1 O HIS A 294 N ILE A 225 SHEET 1 AA4 3 GLY A 200 VAL A 203 0 SHEET 2 AA4 3 ILE A 261 LEU A 265 -1 O SER A 262 N SER A 202 SHEET 3 AA4 3 LYS A 268 LEU A 272 -1 O LEU A 272 N ILE A 261 SHEET 1 AA5 3 LYS A 242 LYS A 243 0 SHEET 2 AA5 3 TYR A 248 LYS A 251 -1 O VAL A 249 N LYS A 242 SHEET 3 AA5 3 LEU A 288 THR A 290 -1 O CYS A 289 N VAL A 250 SHEET 1 AA6 9 GLU B 73 LEU B 76 0 SHEET 2 AA6 9 VAL B 83 VAL B 94 -1 O GLY B 85 N LEU B 74 SHEET 3 AA6 9 GLN B 14 ILE B 21 -1 N GLY B 20 O THR B 93 SHEET 4 AA6 9 SER B 4 TYR B 10 -1 N THR B 8 O TYR B 16 SHEET 5 AA6 9 GLY B 167 LEU B 171 -1 O GLY B 167 N LEU B 7 SHEET 6 AA6 9 VAL B 152 TYR B 157 -1 N SER B 154 O VAL B 170 SHEET 7 AA6 9 PHE B 316 ASP B 321 -1 O PHE B 320 N PHE B 153 SHEET 8 AA6 9 ARG B 326 ALA B 332 -1 O GLY B 328 N GLU B 319 SHEET 9 AA6 9 TYR B 179 ASN B 187 -1 N GLU B 180 O LEU B 331 SHEET 1 AA713 GLU B 73 LEU B 76 0 SHEET 2 AA713 VAL B 83 VAL B 94 -1 O GLY B 85 N LEU B 74 SHEET 3 AA713 ILE B 97 GLU B 108 -1 O PHE B 103 N SER B 88 SHEET 4 AA713 VAL B 39 PRO B 42 1 N VAL B 41 O VAL B 106 SHEET 5 AA713 GLY B 121 GLY B 124 -1 O VAL B 122 N TRP B 40 SHEET 6 AA713 GLN B 26 ASP B 33 1 N VAL B 31 O VAL B 123 SHEET 7 AA713 GLN B 14 ILE B 21 -1 N GLY B 17 O VAL B 30 SHEET 8 AA713 SER B 4 TYR B 10 -1 N THR B 8 O TYR B 16 SHEET 9 AA713 GLY B 167 LEU B 171 -1 O GLY B 167 N LEU B 7 SHEET 10 AA713 VAL B 152 TYR B 157 -1 N SER B 154 O VAL B 170 SHEET 11 AA713 PHE B 316 ASP B 321 -1 O PHE B 320 N PHE B 153 SHEET 12 AA713 ARG B 326 ALA B 332 -1 O GLY B 328 N GLU B 319 SHEET 13 AA713 TYR B 179 ASN B 187 -1 N GLU B 180 O LEU B 331 SHEET 1 AA8 4 SER B 206 LEU B 209 0 SHEET 2 AA8 4 GLN B 195 VAL B 203 -1 N VAL B 201 O LEU B 209 SHEET 3 AA8 4 ILE B 261 LEU B 265 -1 O SER B 262 N SER B 202 SHEET 4 AA8 4 LYS B 268 LEU B 272 -1 O TYR B 270 N PHE B 263 SHEET 1 AA9 6 SER B 206 LEU B 209 0 SHEET 2 AA9 6 GLN B 195 VAL B 203 -1 N VAL B 201 O LEU B 209 SHEET 3 AA9 6 CYS B 214 VAL B 218 -1 O ALA B 216 N ILE B 196 SHEET 4 AA9 6 TRP B 306 LEU B 308 1 O LEU B 308 N LEU B 217 SHEET 5 AA9 6 ILE B 225 GLY B 227 -1 N SER B 226 O ALA B 307 SHEET 6 AA9 6 ILE B 293 ALA B 295 1 O HIS B 294 N ILE B 225 SHEET 1 AB1 4 LYS B 242 LYS B 243 0 SHEET 2 AB1 4 TYR B 248 LYS B 251 -1 O VAL B 249 N LYS B 242 SHEET 3 AB1 4 LEU B 288 LEU B 291 -1 O CYS B 289 N VAL B 250 SHEET 4 AB1 4 VAL B 278 PHE B 279 -1 N PHE B 279 O THR B 290 SSBOND 1 CYS A 46 CYS A 53 1555 1555 2.04 SSBOND 2 CYS A 210 CYS A 214 1555 1555 2.04 SSBOND 3 CYS A 252 CYS A 289 1555 1555 2.04 SSBOND 4 CYS B 46 CYS B 53 1555 1555 2.03 SSBOND 5 CYS B 210 CYS B 214 1555 1555 2.04 SSBOND 6 CYS B 252 CYS B 289 1555 1555 2.04 CISPEP 1 THR A 23 PRO A 24 0 -0.24 CISPEP 2 LEU A 112 PRO A 113 0 0.69 CISPEP 3 PRO A 300 PRO A 301 0 0.09 CISPEP 4 GLY A 303 PRO A 304 0 -0.14 CISPEP 5 THR B 23 PRO B 24 0 0.02 CISPEP 6 LEU B 112 PRO B 113 0 -0.08 CISPEP 7 PRO B 300 PRO B 301 0 0.11 CISPEP 8 GLY B 303 PRO B 304 0 0.03 SITE 1 AC1 22 HOH B 508 THR B 13 GLN B 14 TYR B 15 SITE 2 AC1 22 ASP B 33 GLY B 35 TRP B 40 PRO B 42 SITE 3 AC1 22 HIS B 56 TYR B 78 VAL B 106 MET B 109 SITE 4 AC1 22 PRO B 113 PHE B 114 ALA B 117 PHE B 119 SITE 5 AC1 22 ASP B 120 GLY B 121 VAL B 122 ASP B 219 SITE 6 AC1 22 GLY B 221 SER B 223 CRYST1 141.916 141.916 141.916 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007046 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007046 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007046 0.00000 MTRIX1 1 -0.783580 -0.352380 0.511700 161.09058 1 MTRIX2 1 -0.338540 -0.448420 -0.827230 116.00447 1 MTRIX3 1 0.520950 -0.821430 0.232080 -0.50184 1